Introduction
At the onset of puberty, follicular growth is ac celerated in response to gonadotropin release. Al though there is a striking difference in the distribu tion of blood vessels to individual follicles, the largest and presumably preovulatory follicles ex hibit a high degree of vascularity and are supplied with numerous networks of vessels which project downward to the basement mem brane surround ing the granulosa cells [1] [2] [3] . This increase in vas cularization during follicular growth may be de pendent upon the production of angiogenic factors by the ovary. Ovarian angiogenic factors have been detected in extracts prepared from porcine and bovine corpus lutea [4] [5] [6] [7] , non-luteal mouse ovaries [8] , hum an follicular fluid [9] , porcine and bovine follicles [10] and rat granulosa cells [11] ,
In the present study, glycosaminoglycans was prepared from non-luteal ovaries o f mice treated with follicle-stimulating horm one (FSH) and as sayed for angiogenic activity. Evidence will be pre sented showing that glycosaminoglycans, includ ing a hyaluronic acid-like substance, are involved in neovascularization. 
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Materials and Methods
Chemicals
Ethylenevinyl acetate copolymer (Elvax 40) was purchased from Aldrich Chemical Co.; folliclestimulating hormone (FSH, from porcine pitui tary), Dowex l-x2 (200-400 mesh, Cl-form), DEAE Sephadex A-25 (CF form), streptococcal hyaluronidase, chondroitinase ABC (from Proteus vulgaris) from Sigma Chemical Co.; standard hyal uronic acid (from hum an umbilical cord) from Seikagaku Kogyo Co., Japan.
Preparation o f ovarian extracts
Im m ature female mice (JCL-ICR strain, 4 weeks old, 2 0 -2 2 g body weight) were injected with 1 i.u. of FSH dissolved in 0.3 ml of physiolog ical saline. The injections were repeated after 24 h. The ovaries were excised 24 h after the second injection of FSH. The ovaries were homogenized in 0.5 m ammonium carbonate with an ultrasonicator. The homogenates were centrifuged at 54,000 x g for 1 h. The supernatant was collected, dialyzed against three changes of one liter distilled water, lyophilized and tested for angiogenic activ ity.
Extraction o f glycosaminoglycans
Glycosaminoglycans were prepared from the ovaries according to the method described by Schiller et al. [12] with slight modifications. Ova rian extracts were heated at 100 °C for 15 min and lyophilized. The lyophilized materials (100 mg) were suspended in 10 ml of 0.1 m acetate buffer, pH 5.8, containing 0.005 m cysteine HC1, 1.0 m NaCl, 0.005 m EDTA (disodium salt), activated crystalline papain (2 mg per 120 mg of the lyophil ized extract) and incubated for 24 h at 60 °C.
The solution was dialyzed against distilled water for 24 h at 4 °C and the retentate centrifuged at 2000 x g for 20 min. The protein in the super natant was precipitated by adding trichloroacetic acid (TCA) solution to a final concentration of 10%. The TCA-soluble fraction was dialyzed against distilled water at 4 °C. Glycosaminoglycans were precipitated at 4 °C from the super natant by the addition of three vol. of ethanol con taining 2% sodium acetate (w/v). The precipitated glycosaminoglycans were washed with ethanol, redissolved in water, and fractionated by ionexchange chrom atography.
Chromatography o f glycosaminoglycans
The crude glycosaminoglycans were chrom ato graphed on an anion exchange resin, Dowex l-x2 (200-400 mesh) in the chloride form, and on DEAE Sephadex A-25, Cl-form. Columns, 0.9 cm in diameter, were packed with resins sus pended in water (Dowex) or in a 0.1 m NaCl solu tion (DEAE Sephadex) to a height of 20 cm. A sample of 3 to 5 mg o f glycosaminoglycans dis solved in water was applied. The column was washed with water (Dowex) or 0.1 m NaCl solu tion (DEAE Sephadex), and eluted stepwise with increasing concentrations of NaCl starting with 0.5 m . The am ount of glycosaminoglycans in each fraction was determined by a modified method of Dische's carbazole reaction in the presence of borate as described by Bitter and M uir [13] . The fraction eluted from the Dowex column with 0.5 m NaCl possessed the highest potency and was fur ther purified by high performance liquid chrom a tography (HPLC). The 0.5 m NaCl fraction was dialyzed against distilled water and concentrated to 0.1 ml containing 1 mg of glycosaminoglycans. Any insoluble residue was removed by centrifuga tion in a microfuge. The supernatant was injected into a TSK gel DEAE-2 SW column (15 x 250 mm) (Toyosoda Ltd., Japan). The column was eluted with a linear gradient of water and 2 m NaCl at a flow rate o f 1 ml/min. Fractions of 1 ml were col lected, and glycosaminoglycans detected spectrophotom etrically be measuring the absorbance at 260 nm. Each fraction was dialyzed against dis tilled water and lyophilized.
Degradation o f glycosaminoglycans
HPLC-purified glycosaminoglycans with angio genic activity were dialyzed against three changes of 11 distilled water for 24 h, collected and placed in a boiling water bath for 5 min, and subsequently divided into 5 equal parts (400 (al) containing 200 |ig of HPLC-purified glycosaminoglycans. Aliquots were incubated separately with 100 ng of streptococcal hyaluronidase, 100 (ig of chondroitinase ABC dissolved in 100 |il enzyme buffer (0.1 m N a2H P 0 4/0.lM N aH 2P 0 4, pH 5.6) or 100^1 enzyme buffer alone.
The reaction mixtures were incubated at 37 °C for 3 h. The treated samples were boiled for 5 min and cooled, and cetylpyridinium chloride was add ed to a final concentration o f 1% to precipitate the non-degraded glycosaminoglycans. The resulting precipitate was washed once in cold distilled water, and dialyzed against three changes of 11 distilled water, and lyophilized.
C arrier and cetylpyridinium chloride were add ed to a fourth aliquot o f HPLC-purified glycos aminoglycans with angiogenic activity. A fifth ali quot was subjected to nitrous acid degradation ac cording to the method o f Dische and Borenfreund [14] as modified by Kosher and Searls [15] . Briefly, an equal volume of 5% sodium nitrite and 33% acetic acid was added, the reaction mixture was shaken, stoppered, and left standing at ambient tem perature for 90 min. Undegraded glycos aminoglycans were precipitated with 1% cetylpyri dinium chloride and washed once by resuspending in cold distilled water, and dialyzed against three changes o f 11 distilled water at 4 °C, and lyophil ized.
Bioassay fo r neovascularization
A copolym er of ethylenevinyl acetate (Elvax 40) was washed extensively with ethanol and dissolved in methylene chloride to a final concentration of 12% (w/v). The crude extract and partially puri fied fractions were embedded in the polymer as de-scribed by Gospodarowicz et al. [16] . A drop o f the copolymer solution was applied to a glass slide and dried under partial vacuum for 2 h forming a thin, transparent film. A drop (100 jj.1) o f the 12% Elvax-methylene chloride solution containing the test extract was cut into squares (approximately 2 x 2 mm) with a razor blade. Tissue response to the film alone was determined by im planting films without the test extract into young adult mice (JC L -IC R strain). The tissue around the im plant ed film was examined by a histopathological tech nique. The mice were anesthetized by an intraperitoneal injection of pentobarbital. A superficial incision was made in the abdom inal wall. The im plants of Elvax 40 alone (control) or impregnated with the lyophilized m aterial (test films) were ex posed to ultra-violet light for 2 h and inserted on the lateral wall o f the sheath o f m. rectus abdom i nis. On the 15th day after im plantation, the ab dominal wall was examined for vascularization under a stereo-and inverted light microscope with phase contrast attachm ent. Positive reaction is characterized by a distinct increase in capillary vasculature over the confine of the film. Angio genic activity is scored and recorded as follows: score 0, negative; score 1, ramified capillaries with diameters smaller than 10 )im; score 2, 1 or 2 ram i fied vessels with diameters greater than 10 (im and small capillaries; score 3, 3 or more ramified ves sels with diameters greater than 10 jim and small capillaries; score 4, num erous ramified vessels with diameters exceeding 10 |im, num erous small capil laries and capillary networks. An inflam m atory reaction can be readily recognized by increased vasculature and hyperemic reaction at the periph eral border of the film. P values were calculated by the student t test.
Morphological examination
For electron microscopy studies, tissue samples measuring 1 -2 mm in length were fixed in 3.5% cold, phosphate-buffered glutaraldehyde (pH 7.5) for 2 h. After careful rinsing in buffer, samples were postfixed in 2% 0 s0 4 for 2 h, dehydrated in ethanol, and embedded in Luveak 812 (Nacalai Tesque Co. Ltd., Japan). U ltrathin sections were contrasted with uranyl acetate and lead citrate and viewed under a Hitachi transmission electron microscope Model H-300.
Results
Crude glycosaminoglycans prepared from ova rian extracts induced neovascularization in a dosedependent manner (Table I ). Since neovasculariza tion may occur in association with inflammation, the tissues were examined for signs o f inflam m ato ry reactions. Inflammatory cells were seen in some of the specimens. When the num ber of m acro phages and other inflammatory cells around the films exceeded that observed with plain Elvax film (control), these specimens (about 3% of the films implanted in this series of experiments) were re corded and considered as inflammation and not scored as neovascularization. Crude glycosamino glycans were separated into 4 fractions by chrom a tography on Dowex l-x2 and DEAE-Sephadex A-25 columns eluted with increasing concentra- tions o f NaCl. The fraction eluted with 0.5 m NaCl possessed neovascularizing activity (Table II) . This fraction has been reported to contain hyal uronic acid and chondroitin [12] . The 0.5 m NaCl fraction obtained from the Dowex l-x2 column was further purified by HPLC on a TSK gel DEAE-2SW column. Absorbance of the fraction was measured at 260 nm and the fractions com prising the peaks were pooled (Fig. 1) . The highest biological activity was dem onstrated with tubes No. 2 7 -2 8 . The peak value of reference marker, hyaluronic acid, was identified in tube No. 28. This fraction was effective in inducing neovascu larization at a dose of 5 (ig/implant (Fig. 2, 4) . The biological activity of the HPLC-purified angiogen- ic glycosaminoglycan was reduced on treatm ent with streptococcal hyaluronidase, chondroitinase ABC or nitrous acid. The greatest reduction occurred with hyaluronidase treatm ent (Fig. 3) . Capillary proliferation is characteristic of ac tively growing tissue, such as corpus lutea [4] [5] [6] [7] , ovarian follicles [8 -11] , salivary glands [17] , gran ulation tissues [18] , retina [19] , adrenal glands [20] , tum or [21] , and am inochorion and placenta [22] , Capillary proliferation of angiogenesis involves the outgrowth of new capillaries directed toward a given stimulus. Microscopic examination of capil lary growth revealed that endothelial cells migrate from the tip o f the capillary before mitosis occurs [23] , suggesting that the ability to prom ote direct ed migration of capillary endothelial cells is a pre requisite for angiogenesis [23] , These findings sug gest that multiple factors are involved in the initia tion, migration and proliferation of endothelial cells, and in the form ation o f the "three-dim en sional" network of capillaries.
Several factors have been reported to induce neovascularization such as wound fluid [24] , epi dermal and fibroblast growth factors [16] , tum or extracts [25, 26] , secretions from antigen and phyto hemagglutinin-stimulated lymph node cells [27] and activated macrophages [28] , extracts of corpus luteum and non-luteal ovaries [4] [5] [6] [7] [8] [9] [10] [11] , ovarian folli cular fluid [9] , and conditioning medium o f granu losa cells [ 11 ] . In these cases that angiogenic activity was assayed by in vivo and in vitro systems. Using the in vitro assay system, the process of prolifera tion and the migration of capillary endothelial cells can be measured [29] , M oreover, methods to examine the form ation of extensive network of capillary-like structures from the endothelial cells derived from capillaries in vitro have been devel oped. In vivo assay system for angiogenic activity is based on the appearance of new capillaries on applying the test samples on the surface o f the chorioallantoic membranes of chick embryo [30] , by implanting films on the lateral wall of the sheath of m. rectus abdominis [8] , or by placing the test samples in the corneal pockets [29] . Although the in vivo assays may have physiological rele vance, angiogenic activity is difficult to quantify and the occurrence of artifactual neovasculariza tion due to inflam m atory reactions may be diffi cult to exclude.
Inflammation is the most potent inducer of angiogenesis and is a troublesome source of arti factual capillary proliferation [5, 29] . To exclude inflam m ation and to score as a true non-inflamm atory angiogenic response to the extracts, there should be no edema or leukocytic infiltration about the implants. Neovascularization induced by certain com pounds such as bovine serum albu min (BSA) is characterized by an inflammatory reaction associated with infiltration of leukocytes and m acrophages into the subcutaneous tissues [8] , In the present study inflammation due to im munological reactions was avoided by utilizing inbred mice as the tissue source o f the angiogenic factor and by using the same strain to bioassay for the activity. The films were sterilized by ultra violet light treatm ent to avoid inflam m ation from bacterial infection. By using the sterile techniques outlined, the incidence of non-specific inflam m a tion was minimized to about 3%.
In the present study, we have dem onstrated that the glycosaminoglycans in the 0.5 m NaCl fraction of HPLC-purified ovarian extracts induced capil lary proliferation. This fraction has been reported to contain hyaluronic acid and chondroitin [12] . The active factor was purified by HPLC and elut ed in the fraction with a retention time nearly coin cident with that o f hyaluronic acid. M oreover, its biological activity is markedly reduced on treat-ment with streptococcal hyaluronidase. Ausprunk [31] dem onstrated that precise changes in glycosaminoglycan com position could be correlated with significant events in the development of the chick chorioallantoic m em brane-blood vessels, and that hyaluronic acid might be involved in the form a tion, alignment, or m igration o f the capillary plexus of the chick chorioallantoic membrane.
Feinberg and Beebe [32] reported that vascular regions o f the chick wing bud are rich in hyaluron ic acid and that avascular zones can be induced in the wing bud mesoderm after im planting Elvax containing hyaluronic acid. On the other hand, West et al. [33] showed that partially degraded products o f sodium hyaluronate hydrolyzed with testicular hyaluronidase induced angiogenesis (form ation o f new blood vessels) when applied to the chick chorioallantoic mem brane, although the intact hyaluronate was inactive. Fractionation of the digested products showed that the activity was associated with the hyaluronate fragments con taining 4 to 25 disaccharides in length [33] . We have shown that ovarian hyaluronic acid fraction possessed angiogenic activity when implanted on the lateral wall o f the sheath of m. rectus abdom i nis, and the activity is markedly reduced on treat ment with streptococcal hyaluronidase. The basis for the angiogenic activity dem onstrated with the HPLC-purified hyaluronic acid from mouse ovary is not clear. It is suggested that the hyaluronic acid molecules in the ovaries might have been slightly modified to acquire angiogenic activity during ovarian follicular development or be a degradative form with angiogenic activity. The latter is possi ble since hyaluronic acid is taken up by endothelial cells and degraded to low-molecular weight prod ucts [33] .
Glycosaminoglycans such as heparin potentiate E C G F activity [33, 34] , H eparin and EC G F can increase chemotaxis and chemokinesis of hum an endothelial cells [35] . Tum or EC G F has a strong affinity for heparin [36] and heparin stimulates the m igration o f endothelial cells [29, 37, 38] , Heparin in the ovarian extract should be eluted in the 2 .0 m NaCl fraction o f glycosaminoglycans. This frac tion did not show significant angiogenic activity.
Follicular fluid contain about 0 .2 -0 .3 % (w/v) glycosaminoglycans [39, 40] . These substances are composed o f a core protein o f an estimated M r of 400 kD a with an average o f 20 derm atan sulfate chains and 350 sialic acid-containing oligosaccha rides [41] , and are produced by the follicular cells [42] , Yanagishita and Hascall [40] reported that 90% of the glycosaminoglycans secreted by rat granulosa cells are hydrolyzed by chondroitinase ABC, indicating that the m ajor constituent is chondroitin sulfate. Nevertheless, hyaluronic acid is also present in mam m alian ovaries [42] , During cumulus expansion initiated by FSH, hyaluronic acid is the m ajor glycosaminoglycans produced by the mouse cumulus oocyte complexes [42] , Ball et al. [43] reported that massive am ounts o f glycos aminoglycans accumulated in the matrix envelop ing the cumulus cells during the expansion of bovine cumulus-oocyte complexes induced with FSH or cyclic adenosine 3',5'-m onophosphate. When the intercellular m atrix materials were iso lated and subjected to electrophoretic analysis, the radiolabeled glycosaminoglycans co-migrated with reference hyaluronic acid [43] and hydrolyzed by hyaluronidase. However, it was resistant to chondroitinase ABC and nitrous acid degradation, indicating that the intercellular matrix produced by bovine cumulus-oocyte complexes is rich in hyaluronic acid [43] .
Hyaluronic acid may be responsible for the angiogenesis observed in the ovary and regulated by gonadotropins. There is a general consensus that luteinizing horm one (LH) induces cumulus expansion in vivo [42] . In vitro study has estab lished that FSH is responsible for hyaluronic acid production [44] , It is also noteworthy that FSH can induce cumulus expansion in vitro and stimu lates the synthesis of glycosaminoglycans in the oocyte-cumulus cell complexes in the presence or absence of fetal calf serum (FCS) [45] , In the pres ence of FCS the glycosaminoglycans are retained within the complexes, while in the absence of FCS they are secreted into the culture medium [44, 45] . Taken together, it can be surmised that glycos aminoglycans, especially hyaluronic acid-like substance, are probably involved in the induction of angiogenesis in the ovary during follicular growth initiated by FSH.
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